|Articles|August 31, 2019

N-1 Bioreactor Perfusion Capability

• How alternating tangential filtration differs from other perfusion methods • The benefits of alternating tangential filtration

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Expanding Horizons in Liquid Nasal Drug Development

ByCatalent

June 9th 2026

Sponsored Content

Innovative Screening Strategies for Cyclodextrin Interactions: AI, Computational Models, and Experimental Approaches

ByLigand

June 8th 2026

Sponsored Content

Becoming a Cornerstone of Fujifilm’s CDMO Strategy in Denmark

ByFUJIFILM Biotechnologies

June 5th 2026

Sponsored Content

An Innovative, Modular Approach to Flexible Supply Chain Management

ByFUJIFILM Biotechnologies

June 5th 2026

Sponsored Content

How Integrated Biologics Manufacturing Ecosystem Is Redefining Speed, Scale, and Sustainability

ByFUJIFILM Biotechnologies

June 5th 2026

Sponsored Content

N-1 Bioreactor Perfusion Capability

Related Content

Expanding Horizons in Liquid Nasal Drug Development

Innovative Screening Strategies for Cyclodextrin Interactions: AI, Computational Models, and Experimental Approaches

Becoming a Cornerstone of Fujifilm’s CDMO Strategy in Denmark

An Innovative, Modular Approach to Flexible Supply Chain Management

How Integrated Biologics Manufacturing Ecosystem Is Redefining Speed, Scale, and Sustainability

Trending on Pharmaceutical Technology

Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet

Why the First Generic Single-Dose Flu Antiviral Approval Matters

Germany Pharma Tariff Threat: What Manufacturers Need to Know

PharmTech Weekly Roundup—June 19, 2026

Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next